跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Enaprinova-5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Enaprinova-5
Approved
STANDARD
Enaprinova-5
S Kant Healthcare Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0d8917fc6d33c7c1
Company
S Kant Healthcare Ltd.
Type
Standard
Approval Details
Approval Id
0d8917fc6d33c7c1
Drug Approval Philippines Name
Enaprinova-5
Product Name
Enaprinova-5
Registration Number
DRP-15204
Brand Name
Enaprinova-5
Generic Name
Enalapril maleate
Dosage Form
Tablet
Dosage Strength
5 mg
Manufacturer
S Kant Healthcare Ltd.
Importer
Medinova Pharmaceutical Inc.
Distributor
Medinova Pharmaceutical Inc.
Issuance Date
24 May 2024
Expiry Date
24 May 2029
Pharmacologic Category
Angiotensin-converting Enzyme (ACE) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0d8917fc6d33c7c1
Type
Standard
Back to Philippines FDA Approvals